Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Greenwich LifeSciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $310.63M | $310.63M - $310.63M | $0.00 | $9.90 | 1 |
| Dec 2028 | $140.00M | $140.00M - $140.00M | $0.00 | $3.98 | 1 |
| Dec 2027 | $8.75M | $8.75M - $8.75M | $0.00 | -$1.47 | 1 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.35 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.225 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.80 | 0 |